Company intelligence / Profile preview
Afecta Pharmaceuticals
Irvine, California, United Statesafectapharm.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Afecta Pharmaceuticals develops precision medicines using AI-driven platforms targeting chronic diseases and cancers. Lead assets include small molecule drugs in early clinical stages across neurology, dermatology, oncology, and ophthalmology. The company has demonstrated bioactivity of its compounds in animal/tissue models and holds patents on novel anti-inflammatory pathways such as CCL5/RANTES inhibition. Some assets have been licensed to Supernus Pharmaceuticals.
- Therapeutic areas
- OncologyImmunologyDermatologyOphthalmologyNeurology
- Modalities
- Small moleculesChemical drugsNovel drug delivery technologies
- Industry
- Biotech
02
Drug pipeline
20 assets19 more assets in the full pipeline.
Request access →03
Partnerships
Supernus Pharmaceuticals Inc. (NASDAQ: SUPN)Allergan PLC/AbbVie Inc.LEO Pharma A/S
Beyond the preview
Go deeper on Afecta Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Afecta Pharmaceuticals.